| Literature DB >> 30665713 |
Christine H Holschneider1, Daniel G Petereit2, Christina Chu3, I-Chow Hsu4, Yevgeniya J Ioffe5, Ann H Klopp6, Bhavana Pothuri7, Lee-May Chen8, Catheryn Yashar9.
Abstract
Brachytherapy is well-established as an integral component in the standard of care for treatment of patients receiving primary radiotherapy for cervical cancer. A decline in brachytherapy has been associated with negative impacts on survival in the era of modern EBRT techniques. Conformal external beam therapies such intensity modulated radiation therapy (IMRT) or stereotactic body radiation therapy (SBRT) should not be used as alternatives to brachytherapy in patients undergoing primary curative-intent radiation therapy for cervical cancer. Computed tomography or magnetic resonance image-guided adaptive brachytherapy is evolving as the preferred brachytherapy method. With careful care coordination EBRT and brachytherapy can be successfully delivered at different treatment centers without compromising treatment time and outcome in areas where access to brachytherapy maybe limited.Entities:
Keywords: Brachytherapy; Cervical cancer; IMRT; Primary chemoradiation; SBRT
Mesh:
Year: 2019 PMID: 30665713 DOI: 10.1016/j.brachy.2018.11.009
Source DB: PubMed Journal: Brachytherapy ISSN: 1538-4721 Impact factor: 2.362